We are live on
!
Find out more
TCM
TimesSquare Capital Management Portfolio holdings
AUM
$6.8B
1-Year Est. Return
45.85%
This Fund
S&P 500
This Quarter
Est. Return
+2.56%
1 Year Est. Return
+45.85%
3 Year Est. Return
+131.54%
5 Year Est. Return
+149.79%
10 Year Est. Return
+765.84%
AUM
$14.9B
AUM Growth
-$546M
(-3.5%)
Cap. Flow
-$733M
Cap. Flow
% of AUM
-4.91%
Top 10 Holdings %
Top 10 Hldgs %
14.38%
Holding
265
New
26
Increased
86
Reduced
129
Closed
24
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bio-Rad Laboratories Class A
BIO
|
+$89M |
| 2 |
Progressive
PGR
|
+$88.3M |
| 3 |
SBNY
Signature Bank
SBNY
|
+$87.7M |
| 4 |
Expedia Group
EXPE
|
+$65.6M |
| 5 |
EFII
Electronics for Imaging
EFII
|
+$61.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NLSN
Nielsen Holdings plc
NLSN
|
+$103M |
| 2 |
AWH
Allied World Assurance Co Hld Lt
AWH
|
+$92.4M |
| 3 |
COL
Rockwell Collins
COL
|
+$75.8M |
| 4 |
SIVB
SVB Financial Group
SIVB
|
+$74.9M |
| 5 |
International Flavors & Fragrances
IFF
|
+$73.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 23.05% |
| 2 | Technology | 17.2% |
| 3 | Consumer Discretionary | 12.35% |
| 4 | Healthcare | 10.46% |
| 5 | Financials | 10.18% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
226
Intuit
INTU
$89B
| $6.39M | 0.04% |
55,740
-14,255
| -20% | -$1.6M |
|
227
Cardinal Health
CAH
$55.4B
| $5.79M | 0.04% |
80,493
-6,335
| -7% | -$458K |
|
|
TMHC
228
DELISTED
Taylor Morrison
TMHC
| $5.58M | 0.04% |
289,500
-1,374,300
| -83% | -$25.8M |
|
229
Starbucks
SBUX
$120B
| $4.75M | 0.03% |
85,592
-38,305
| -31% | -$2.12M |
|
|
AGN
230
DELISTED
Allergan plc
AGN
| $4.54M | 0.03% |
21,614
-1,990
| -8% | -$412K |
|
231
Netflix
NFLX
$309B
| $4.47M | 0.03% |
+360,900
| New | +$4.28M |
|
|
ALXN
232
DELISTED
Alexion Pharmaceuticals
ALXN
| $4.26M | 0.03% |
34,835
+5,895
| +20% | +$721K |
|
233
Amazon
AMZN
$2.96T
| $3.72M | 0.02% |
+99,120
| New | +$3.88M |
|
|
CORE
234
DELISTED
Core Mark Holding Co., Inc.
CORE
| $1.95M | 0.01% |
+45,200
| New | +$1.67M |
|
235
iShares Russell Mid-Cap Growth ETF
IWP
$20.7B
| $1.34M | 0.01% |
27,600
+3,800
| +16% | +$183K |
|
236
iShares MSCI India ETF
INDA
$6.63B
| $146K | ﹤0.01% |
+5,400
| New | +$150K |
|
237
WisdomTree India Earnings Fund ETF
EPI
$2.06B
| $67K | ﹤0.01% |
+3,300
| New | +$68.6K |
|
238
VanEck India Growth Leaders ETF
GLIN
$95.5M
| $67K | ﹤0.01% |
+1,600
| New | +$70.9K |
|
|
CLC
239
DELISTED
Clarcor
CLC
| $41K | ﹤0.01% |
500
-546,000
| -100% | -$38.5M |
|
|
SCIN
240
DELISTED
Columbia India Small Cap ETF
SCIN
| $29K | ﹤0.01% |
+2,000
| New | +$30.7K |
|
241
Acadia Pharmaceuticals
ACAD
$5.03B
| – | – |
-383,200
| Closed | -$12.2M |
|
242
Blackbaud
BLKB
$2.08B
| – | – |
-627,300
| Closed | -$41.6M |
|
243
Salesforce
CRM
$158B
| – | – |
-50,740
| Closed | -$3.62M |
|
244
Exponent
EXPO
$3.24B
| – | – |
-1,744,000
| Closed | -$50.6M |
|
245
Globus Medical
GMED
$11.2B
| – | – |
-1,546,744
| Closed | -$34.9M |
|
|
246
International Flavors & Fragrances
IFF
$21.9B
| – | – |
-511,300
| Closed | -$73.1M |
|
247
iShares Russell 2000 Growth ETF
IWO
$15.1B
| – | – |
-70,000
| Closed | -$10.4M |
|
248
Nordson
NDSN
$17.3B
| – | – |
-132,000
| Closed | -$13.2M |
|
249
Nike
NKE
$61.9B
| – | – |
-129,685
| Closed | -$6.83M |
|
250
Robert Half
RHI
$4.37B
| – | – |
-882,500
| Closed | -$33.4M |
|
Similar funds
CF
JCAM
GAM
CIMLRA
TAM
SPC
SPS
BHM
TimesSquare Capital Management's Q4 2016 Portfolio in Review
As of Q4 2016, TimesSquare Capital Management held 265 positions worth $14.9B, down 3.5% from $15.5B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
TimesSquare Capital Management withdrew a net $733M in Q4 2016, closing 24 positions and reducing 129 holdings. Its most notable exit was Rockwell Collins, an estimated $75.8M position sold in full.
By sector, the portfolio is most concentrated in Industrials at 23% of assets, down from 23% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, TimesSquare Capital Management opened a new position in Bio-Rad Laboratories Class A worth $95.1M.
- TimesSquare Capital Management's largest Q4 2016 buy was Bio-Rad Laboratories Class A: 521,900 shares worth $95.1M.
- TimesSquare Capital Management added most to Electronics for Imaging in Q4 2016, an estimated $61.5M increase.
- TimesSquare Capital Management's biggest Q4 2016 reduction was Nielsen Holdings plc, cutting an estimated $103M.
- TimesSquare Capital Management fully exited Rockwell Collins in Q4 2016, selling an estimated $75.8M.
- TimesSquare Capital Management's ten largest holdings make up 14% of its $14.9B portfolio in Q4 2016.
- TimesSquare Capital Management opened 26 new positions and closed 24 in Q4 2016.
- TimesSquare Capital Management's portfolio value fell 3.5% quarter-over-quarter to $14.9B.
Based on TimesSquare Capital Management's 13F filing for Q4 2016, filed 13 Feb 2017.